Skip to content

Clinical trials

Terminated Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Status: Terminated Country / region: Australia Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20073
20101
20111
20125
20132
20144
20152
20174
20185
201912
20206
20217
20224
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated60

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie11
GlaxoSmithKline5
Adaptimmune3
Clovis Oncology, Inc.3
Pfizer3
Amgen2
Bristol-Myers Squibb2
Hoffmann-La Roche2
Ludwig Institute for Cancer Research2
Merck Sharp & Dohme LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms60
Carcinoma, Non-Small-Cell Lung11
Neoplasm Metastasis10
Melanoma9
Recurrence9
Colorectal Neoplasms6
Head and Neck Neoplasms5
Leukemia, Myeloid, Acute5
Breast Neoplasms4
Carcinoma, Hepatocellular4

Trials

Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.